🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs
4,713

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Page 42 of 99

  1. FHD-286

    Foghorn Therapeutics

    Advanced Hematologic Malignancy

    phase 1 small molecule active

    1 trial

  2. FHD-286

    Foghorn Therapeutics

    Metastatic Uveal Melanoma

    phase 1 small molecule terminated

    1 trial

  3. FHD-609

    Foghorn Therapeutics

    Advanced Synovial Sarcoma

    phase 1 small molecule terminated

    1 trial

  4. FMP012 with AS01B adjuvant system

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  5. FMP1/AS02A

    United Therapeutics Europe Ltd

    Malaria

    phase 1 mab completed

    1 trial

  6. FMT capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    phase 1 mab active

    1 trial

  7. FMX-101

    VYNE Therapeutics

    Healthy

    phase 1 small molecule completed

    3 trials

  8. FMX101

    VYNE Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  9. FMX101 vehicle

    VYNE Therapeutics

    Acne Vulgaris

    phase 1 small molecule completed

    1 trial

  10. FMX101, Minocycline 4% foam

    VYNE Therapeutics

    Acne

    phase 1 small molecule completed

    1 trial

  11. FP-1039

    Prime Medicine

    Advanced Cancer

    phase 1 small molecule completed

    1 trial

  12. FP01

    Avalo Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  13. FPA008

    Prime Medicine

    Healthy

    phase 1 small molecule terminated

    1 trial

  14. FPA144

    Prime Medicine

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  15. FPA150

    Prime Medicine

    Breast Cancer

    phase 1 mab terminated

    1 trial

  16. FPT155

    Prime Medicine

    Advanced Solid Tumors

    phase 1 mab terminated

    1 trial

  17. FT-003

    The First People's Hospital of Lianyungang

    Neovascular Age-related Macular Degeneration

    phase 1 gene therapy active

    1 trial

  18. FT-003

    The First People's Hospital of Lianyungang

    Diabetic Macular Edema

    phase 1 gene therapy active

    1 trial

  19. FT500

    Zafatek

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  20. FT516

    Zafatek

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  21. FT516

    Zafatek

    Acute Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  22. FT522

    Zafatek

    Relapsed/Refractory B-Cell Lymphoma

    phase 1 small molecule completed

    1 trial

  23. FT536

    Zafatek

    Non Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  24. FT536

    Zafatek

    Astrocytoma

    phase 1 mab active

    1 trial

  25. FT538

    Zafatek

    Acute Myeloid Leukemia

    phase 1 small molecule terminated

    1 trial

  26. FT538

    Zafatek

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  27. FT576 (Allogenic CAR NK cells with BCMA expression)

    Zafatek

    Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  28. FT596

    Zafatek

    Lymphoma, B-Cell

    phase 1 small molecule terminated

    1 trial

  29. FT596

    Zafatek

    Diffuse Large B Cell Lymphoma

    phase 1 small molecule terminated

    1 trial

  30. FT819

    Zafatek

    Lymphoma, B-Cell

    phase 1 small molecule active

    1 trial

  31. FT819

    Zafatek

    Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)

    phase 1 small molecule active

    1 trial

  32. FT819 in B-cell Mediated Autoimmune Diseases

    Zafatek

    B-cell Mediated Autoimmune Diseases

    phase 1 other active

    1 trial

  33. FT825

    Zafatek

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  34. FT836

    Zafatek

    Non-Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  35. FTX-6058/placebo oral capsule(s)

    Fulcrum Therapeutics

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  36. FVH1 - a DNA-based influenza vaccine

    INOVIO PHARMACEUTICALS, INC.

    Influenza, Human

    phase 1 mab completed

    1 trial

  37. FX201

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 1 mab active

    1 trial

  38. FX301

    Pacira Ireland Limited

    Pain, Postoperative

    phase 1 small molecule completed

    1 trial

  39. FYU-981

    Mochida Pharmaceutical Company,

    Healthy

    phase 1 small molecule completed

    1 trial

  40. Famciclovir 500 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  41. Fasinumab

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  42. Fasinumab AI

    Regeneron UK Limited

    Osteoarthritis, Knee

    phase 1 small molecule completed

    1 trial

  43. Fast Dual CAR-T Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    B-cell Lymphoma

    phase 1 mab terminated

    1 trial

  44. Faster Aspart

    Novo Nordisk A/S

    Diabetes Mellitus, Type 1

    phase 1 small molecule completed

    1 trial

  45. Fazirsiran

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  46. Febuxostat XR

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  47. Febuxostat XR

    Takeda

    Gout

    phase 1 small molecule completed

    1 trial

  48. Febuxostat XR 80 mg Capsule F1

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.